Pharma Archives - Page 64 of 64 - Life Sciences Times

Ensoma Receives FDA Clearance to Begin Clinical Trials for First In Vivo Gene Insertion Therapy for X-CGD

May 12, 2025

Despite Anti-Vaccine Rhetoric, Global Healthy Living Foundation Sees Strong Interest in Vaccine Education from Chronically Ill Patients

May 9, 2025

Viridian Therapeutics’ Veligrotug Earns FDA Breakthrough Therapy Designation for Thyroid Eye Disease

May 8, 2025

THIS WEEK'S STORIES

Deerfield Management Closes $600 Million Healthcare Venture Fund to Back Next-Generation Innovations

May 5, 2025

FDA Advisory Committee to Review UroGen’s UGN-102 Bladder Cancer Treatment on May 21

May 7, 2025

QuantHealth Launches First Clinical AI Foundation Model for Life Sciences Industry

May 9, 2025

ABOUT US

Life Science Times is New England’s premier life sciences publication, covering the Pharma, Biotech, MedTech and Public Health sectors nationwide with a special focus on New England. Updated daily, we cover the latest news in everything else that touches any rubric of the rapidly growing life sciences industry.

Pharma

Ensoma Receives FDA Clearance to Begin Clinical Trials for First In Vivo Gene Insertion Therapy for X-CGD

Pioneer Institute Tool Finds Drug Price Controls Raising Costs for Many Medicare Patients

What’s a fair price for a drug that’s never developed?

AstraZeneca’s IMFINZI Shows Significant Benefit in Early Bladder Cancer, Phase III Trial Finds

Viridian Therapeutics’ Veligrotug Earns FDA Breakthrough Therapy Designation for Thyroid Eye Disease

Most Read

Zynex Submits FDA Application for Breakthrough Laser Pulse Oximeter

Dr. Ellen Marmur Joins MedSpa Partners, Strengthening Northeast Presence and Industry Leadership

Ted Myles Named CEO of Cellarity as Company Prepares for First Clinical Trial

XPRIZE Healthspan Awards First Round of Winners in $101M Global Competition to Advance Healthy Aging

EDITOR PICKS

Ensoma Receives FDA Clearance to Begin Clinical Trials for First In Vivo Gene Insertion Therapy for X-CGD

Despite Anti-Vaccine Rhetoric, Global Healthy Living Foundation Sees Strong Interest in Vaccine Education from Chronically Ill Patients

Viridian Therapeutics’ Veligrotug Earns FDA Breakthrough Therapy Designation for Thyroid Eye Disease

THIS WEEK'S STORIES

Deerfield Management Closes $600 Million Healthcare Venture Fund to Back Next-Generation Innovations

FDA Advisory Committee to Review UroGen’s UGN-102 Bladder Cancer Treatment on May 21

QuantHealth Launches First Clinical AI Foundation Model for Life Sciences Industry

POPULAR CATEGORY

ABOUT US

FOLLOW US